Explore / Clinical trial
Clinical trial

Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers

Robin Carhart-Harris, PhD, MARecruitingPhase 2Started Oct 20, 2024120 enrolledUnited StatesNCT06626139

Abstract

One hundred twenty healthy participants, ages 21 to 70, who experience moderate-to-lower-than-average mental well-being will be evenly randomized into four different study arms, using a 2x2 factorial design. Depending on the study arm, participants will either receive an inactive placebo or up to 25mg psilocybin (oral dose), in one of two set and setting conditions; drug administration contexts that are predicted to modulate drug effects. The purpose of this study is to evaluate any interaction effects between an oral dose of psilocybin and the surrounding context (set and setting).

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Psilocybin

Keywords

well-beingpsychedelicneuroimaginghealthy volunteersHealthy Participants With Lower-than-average Mental Well-being

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.